Applicant, as named in the Orange Book

Cheplapharm

Next listed expiry: Valcyte on 11 Dec 2027. 1 products with live protection, 10 without.

Products with listed protection

Drug	Ingredient	NDA	Earliest generic entry	Basis
Valcyte valganciclovir hydrochloride	valganciclovir hydrochloride	022257	11 Dec 2027	patent

Recent events

25 Oct 2026Zyprexa · Generic approved 23 Jan 2026
25 Oct 2026Valcyte · Generic approved 19 Mar 2026
25 Oct 2026Zyprexa · Generic approved 5 Mar 2026

Products without listed protection (10)

Drug	Ingredient	NDA	Earliest generic entry	Basis
Etopophos Preservative Free etoposide phosphate	etoposide phosphate	020457	open now	no listed protection
Klonopin · 3 strengths clonazepam	clonazepam	017533	open now	no listed protection
Pulmicort Flexhaler · 2 strengths budesonide	budesonide	021949	open now	no listed protection
Seroquel · 6 strengths quetiapine fumarate	quetiapine fumarate	020639	open now	no listed protection
Seroquel Xr · 5 strengths quetiapine fumarate	quetiapine fumarate	022047	open now	no listed protection
Xenical orlistat	orlistat	020766	open now	no listed protection
Zyprexa · 6 strengths olanzapine	olanzapine	020592	open now	no listed protection
Zyprexa olanzapine	olanzapine	021253	open now	no listed protection
Zyprexa Relprevv · 3 strengths olanzapine pamoate	olanzapine pamoate	022173	open now	no listed protection
Zyprexa Zydis · 4 strengths olanzapine	olanzapine	021086	open now	no listed protection